Lieberman concludes the hearing with thanks.
05/06/2009
https://www.congress.gov...
So what happened was that this brilliant idea of ours did not seem so brilliant to the generic drug industry which did n...
That is a great question.
Our judgment is that it is an old system, it is using old technology, and, frankly, it is not up to the challenge.
If we make our commitments, we must follow through.